News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Liu David Y
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/17/2022 |
4
| Liu David Y (Chief R&D Strategy Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Exercised 13,767 options to buy
@ $0.87, valued at
$12k
Exercised 9,726 options to buy
@ $1.89, valued at
$18.4k
Exercised 5,999 options to buy
@ $1.89, valued at
$11.3k
Exercised 35,656 options to buy
@ $1.16, valued at
$41.4k
Exercised 35,331 options to buy
@ $4.21, valued at
$148.7k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Liu David Y (Chief Scientific Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 10,000 shares
@ $0
Granted 60,000 options to buy
@ $28.73, valued at
$1.7M
|
|
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2019 |
4
| Liu David Y (Chief Scientific Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 15,000 shares
@ $0
Sold 810 shares
@ $8.03, valued at
$6.5k
Granted 90,000 options to buy
@ $8.02, valued at
$721.8k
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2018 |
4
| Liu David Y (Chief Scientific Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 25,800 shares
@ $0
Granted 17,200 options to buy
@ $8.58, valued at
$147.6k
|
|
| 03/13/2018 |
4
| Liu David Y (Chief Scientific Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Sold 3,500 shares
@ $21.2857, valued at
$74.5k
Exercised 3,500 options to buy
@ $4.21, valued at
$14.7k
|
|
| 03/02/2018 |
4
| Liu David Y (Chief Scientific Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 9,500 shares
@ $0
Sold 875 shares
@ $20, valued at
$17.5k
Granted 56,500 options to buy
@ $16.95, valued at
$957.7k
Exercised 875 options to buy
@ $1.89, valued at
$1.7k
|
|
| 01/17/2018 |
4
| Liu David Y (Chief Scientific Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Sold 875 shares
@ $20, valued at
$17.5k
Exercised 875 options to buy
@ $1.89, valued at
$1.7k
|
|
| 12/20/2017 |
4
| Liu David Y (Chief Scientific Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Sold 875 shares
@ $20, valued at
$17.5k
Exercised 875 options to buy
@ $1.89, valued at
$1.7k
|
|
| 12/01/2017 |
4
| Liu David Y (Chief Scientific Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 875 shares
@ $1.89, valued at
$1.7k
Sold 875 shares
@ $20, valued at
$17.5k
Exercised 875 options to buy
@ $1.89, valued at
$1.7k
|
|
| 11/15/2017 |
4
| Liu David Y (Chief Scientific Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Sold 3,500 shares
@ $16.9659, valued at
$59.4k
Exercised 3,500 options to buy
@ $4.21, valued at
$14.7k
Exercised 3,500 options to buy
@ $1.89, valued at
$6.6k
|
|
| 08/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|